Connect with us

Life Sciences

23andMe Launches Prevention-Based Health Membership, Total Health

What You Should Know: – 23andMe has launched 23andMe+ Total Health, a comprehensive prevention-based health membership. – Total Health provides clinical-grade…

Published

on

This article was originally published by HIT Consultant
23andMe Launches Prevention-Based Health Membership, Total Health

What You Should Know:

23andMe has launched 23andMe+ Total Health, a comprehensive prevention-based health membership.

– Total Health provides clinical-grade exome sequencing, biannual blood testing, genetics-based clinical care, and access to clinicians trained in genetics.

Comprehensive, Prevention-Based Health Membership

The offering aims to provide a comprehensive approach to prevention, enhancing patient understanding of disease risks and leading to healthier lives. Key features include:

– Exome sequencing: Members will receive genetic testing for 55+ health conditions, offering insights into preventive measures and early detection.

– Biannual Blood Testing: Comprehensive blood tests for 55+ biomarkers, going beyond your routine labs. Members will receive biannual testing, allowing them to track results and measure progress all within their 23andMe account through the Lab Results & Vitals feature.

– Access to clinicians trained in genetics:  Clinicians review genetic and blood data, personal and family medical history, and provide personalized risk assessments and preventive health plans. Members are able to engage in an annual virtual clinician consultation, as well as have ongoing messaging conversations with clinicians about their reports, progress they are making, or to ask questions.

– 23andMe+ Premium Membership: Members also gain access to all premium reports and features including Health + Ancestry Service, polygenic reports, pharmacogenetic reports, and enhanced ancestry features.

23andMe+ Total Health Pricing & Availability

Total Health is available for individuals aged 18 and older in the United States, excluding Hawaii, New Jersey, New York, Oklahoma and Rhode Island, and costs $99 per month, billed in a one-time annual payment of $1,188. It will be offered to existing 23andMe customers as an upgrade in the spring of 2024.

“We’re bringing the power of genetics into your personal healthcare journey, along with blood biomarkers, personal and family health history and lifestyle to help you understand the full picture of your disease risks,” said 23andMe’s Vice President of Genomic Health Noura Abul-Husn, M.D. Ph.D. “We’re also helping you understand what to do with this information through clinician consultations and ongoing access to medical professionals. We believe this type of comprehensive approach to prevention will lead to longer, healthier lives.”

biomarkers

Life Sciences

Wittiest stocks:: Avalo Therapeutics Inc (NASDAQ:AVTX 0.00%), Nokia Corp ADR (NYSE:NOK 0.90%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Spellbinding stocks: LumiraDx Limited (NASDAQ:LMDX 4.62%), Transocean Ltd (NYSE:RIG -2.67%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner

The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….

Continue Reading

Trending